Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
Fresh 2026-07-28 Q2 upside surprise: EPS of $2.51 beat $0.89 expected, revenue and profit beat, net income topped $1B, and management raised the 2026 outlook. The earnings catalyst and healthcare defensiveness offset the still-recovering technical setup.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ā¢ Quarterly Recovery ā¢ Strong Liquidity ā¢ Legacy Losses CNC's strong quarterly profit, cash flow, and net cash position signal recovery, but 2025 losses, leverage, intangibles, and a less-cheap valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ā¢ Weakening Momentum ā¢ Key Support ā¢ Upside Trigger Support Level: $64.00ā$64.60 Resistance Level: $67.00ā$67.70; stronger at $69.41 CNC remains modestly positive over the last month but faces near-term pressure below key averages, with $64.00ā$64.60 support and a move above $67.70 needed to revive upside toward $69.41.
Sentiment & News
Key News Insights: ā¢ Earnings Momentum ā¢ Valuation Appeal ā¢ Medicaid Pressure Centene's turnaround momentum, stronger pricing, and improving estimates support a constructive outlook, though Medicaid attrition remains a key risk.
AI Summary
Centene has shifted from a cheap enrollment-growth turnaround to a margin-execution story: after its rally into the mid-$60s, investors should require sustained proof that pricing and medical-cost discipline can offset a projected 9% Medicaid membership decline, as policy or utilization setbacks could quickly reverse the recovery.
Description
Centene Corporation is a multinational healthcare company that provides programs and services primarily for under-insured and uninsured individuals in the U.S., delivering government-funded managed care across Medicaid, CHIP, long-term services and supports, foster care, and plans for dually eligible and disabled populations, alongside commercial insurance products. Its offerings span clinical and non-clinical care coordination, pharmacy and behavioral health services, telehealth and home-based care, and supplemental services for vision, dental and transportation; a separate specialty-services unit provides pharmacy benefits management, nurse advice lines, correctional and military health support, and related staffing. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 28 | Aug 4 | CNC | Centene Corporation | Fresh 2026-07-28 Q2 upside surprise: EPS of $2.51 beat $0.89 expected, revenue and profit beat, net income topped $1B, and management raised the 2026 outlook. The earnings catalyst and healthcare defensiveness offset the still-recovering technical setup. | Closed | +0.3% |
| Apr 28 | May 5 | CNC | Centene Corporation | Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment. | Closed | +6.9% |